Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: A single-center comparative analysis of genoidentical, haploidentical or unrelated donors

Bone Marrow Transplantation

Volumn 33, Issue 11, 2004, Pages 1089-1095

  Caillat Zucman, S ^a   Le Deist, F ^a   Haddad, E ^a   Gannage M ^a   Dal Cortivo, L ^a   Jabado, N ^a   Hacein Bey Abina, S ^a   Blanche, S ^a   Casanova, J L ^a   Fischer, A ^a   Cavazzana Calvo, M ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Graft versus host reaction; HLA matching; Immunodeficiency

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; GENETIC DISORDER; GENOTYPE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEALTH CARE FACILITY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; SIBLING; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENETIC DISEASES, INBORN; GENOTYPE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; OPPORTUNISTIC INFECTIONS; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME;

EID: 2942720464     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704510     Document Type: Article

References (34)

1. Hansen JA, Petersdorf E, Martin PJ, Anasetti C. Hematopoietic stem cell transplants from unrelated donors. Immunol Rev 1997; 157: 141-151.
2. Fischer A, Landais P, Friedrich W et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990; 336: 850-854.
3. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765-771.
4. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
5. Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997; 157: 153-166.
6. Tiercy JM, Villard J, Roosnek E. Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays. Transpl Immunol 2002; 10: 215-221.
7. Scott I, O'Shea J, Bunce M et al. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. Blood 1998; 92: 4864-4871.
8. Speiser DE, Tiercy JM, Rufer N et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996; 87: 4455-4462.
9. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962-968.
10. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
11. Devergie A, Apperley JF, Labopin M et al. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 11-19.
12. Petersdorf EW, Hansen JA, Martin PJ et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001; 345: 1794-1800.
13. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515-3520.
14. Sasazuki T, Juji T, Morishima, Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998; 339: 1177-1185.
15. Drobyski WR, Klein J, Flomenberg N et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 2002; 99: 806-814.
16. Petersdorf EW, Anasetti C, Martin PJ, Hansen JA. Tissue typing in support of unrelated hematopoietic cell transplantation. Tissue Antigens 2003; 61: 1-11.
17. Casper J, Camitta B, Truitt R et al. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354-2363.
18. Oakhill A, Pamphilon DH, Potter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574-578.
19. Woolfrey AE, Anasetti C, Storer B et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 2002; 99: 2002-2008.
20. Al-Kasim FA, Thornley I, Rolland M et al. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Br J Haematol 2002; 116: 483-490.
21. Veys PA, Meral A, Hassan A et al. Haploidentical related transplants and unrelated donor transplants with T cell addback. Bone Marrow Transplant 1998; 21 (Suppl. 2): S42-S44.
22. Jabado N, Le Deist F, Cant A et al. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics 1996; 98: 420-428.
23. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in 'human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
24. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993; 81: 1923-1932.
25. Prasad VK, Heller G, Kernan NA et al. The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles. Transplantation 1999; 68: 1044-1050.
26. Hurley CK, Baxter-Lowe LA, Begovich AB et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant 2000; 25: 385-393.
27. El Kassar N, Legouvello S, Joseph CM et al. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs. Bone Marrow Transplant 2001; 27: 35-43.
28. Fleischhauer K, Kernan NA, O'Reilly RJ et al. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990; 323: 1818-1822.
29. Ferrara GB, Bacigalupo A, Lamparelli T et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001; 98: 3150-3155.
30. Guardiola P, Pasquini R, Dokal I et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422-429.
31. Antoine C, Muller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361: 553-560.
32. Green A, Clarke E, Hunt L et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts; from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 1999; 94: 2236-2246.
33. Andre-Schmutz I, Le Deist F, Hacein-Bey-Abina S et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 2002; 360: 130-137.
34. Guinan EC, Boussiotis VA, Neuberg D et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999; 340: 1704-1714.